Sharescart Research Club logo
Apollo Green 72 (28.6%)ASK Investment 895 (-3.2%)AVPL 49 (0%)Bootes Impex 775 (-8.8%)CIAL 442 (-0.5%)CSK 254 (-3.1%)ESDS Software 478 (2.8%)Garuda Aerospace 468 (-2.1%)Goodluck Defence 385 (16%)Hero Motors 325 (0%)Hinduja Leyland 248 (0%)ICL Fincorp 25 (0%)Incred Holdings 154 (2.7%)Kineco Limited 3285 (0%)Lava 60 (15.4%)Market Simplified 26 (-7.1%)Matrix Gas 12 (-20%)Motilal Oswal 12.25 (-2%)MSEI 6.35 (-2.3%)NCDEX 368 (-1.6%)NSE 1985 (-2%)Onix Renewable 68 (21.4%)OYO 23 (-4.2%)OYO Assets 9.25 (-7%)Philips India 1250 (0%)Polymatech Electronics 56 (-3.4%)SBI Mutual 768 (-0.9%)Taparia Tools 6050 (0%)VCI Chemical 64 (0%)Zepto 40 (-4.8%)

15 Days Price Change

Yatharth Hospital IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size --
Profile
Price Range 285  to  300 per share
Profile
Min Investment ₹300
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Yatharth Hospital and Trauma Care Services Ltd is a leading healthcare institution dedicated to providing comprehensive medical services. With a focus on patient-centric care, the company offers state-of-the-art facilities and a team of highly skilled healthcare professionals. Specializing in trauma care, Yatharth Hospital is equipped to handle emergencies and critical cases with utmost expertise and efficiency. Additionally, the hospital excels in various medical specialties, including cardiology, orthopedics, neurology, and more. Committed to delivering superior healthcare solutions, Yatharth Hospital aims to enhance the well-being of patients and their families, ensuring a compassionate and healing environment. Read More

Basic Info

Face Value 10 per share

Price 285  to  300 per share

P/E (x) 20.4

Sales( Cr.) 880

PAT( Cr.) 131

EPS 14.7

Draft Prospectus

Exchange BSE-NSE

Promoter

Company Promoters

Ajay Kumar Tyagi Kapil Kumar

Pre Issue Share Holding 100%

Post Issue Share Holding 52.1%

Listing Details:

Listing Price: 304

Listing Gain: 1.32%

Current Price: 796.5

Gain On Issue: 796.5 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Jul 26, 2023
Closing Date Jul 28, 2023
Allotment Jul 31, 2023
Refund Aug 01, 2023
Delivery of Shares Aug 01, 2023
Listing Date Aug 02, 2023

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 50 15,000
Retail (Max) 13 650 195,000
S-HNI (Min) 14 700 210,000
S-HNI (Max) 66 3300 990,000
B-HNI (Min) 67 3350 1,005,000

Objective of the Issue

1. Repayment/prepayment, in full or part, of certain borrowings availed by the Company. 2. Repayment/prepayment, in full or part, of certain borrowings availed by the Subsidiaries, namely, AKS Medical & Research Centre Private Limited and Ramraja Multispeciality Hospital & Trauma Centre Private Limited. 3. Funding capital expenditure expenses of the Company for two hospitals, namely, Noida Hospital and Greater Noida Hospital. 4. Funding capital expenditure expenses of the Subsidiaries, AKS and Ramraja, for respective hospitals operated by them. 5. Funding inorganic growth initiatives through acquisitions and other strategic initiatives. 6. General corporate purposes.

Issue

Category Nos Bid Bid (x)
QIB 0 0 0x
NII 0 0 0x
Retail 0 0 0x
EMP 0 0 0x
Total 0 0 0x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Yatharth Hospital Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 102 146 229 401 520 671 880
Other Income 0 0 1 2 3 16 16
Total Income 102 146 229 403 523 686 897
Total Expenditure 82 108 161 289 385 489 655
Operating Profit 20 39 69 114 138 198 241
Interest 7 20 20 23 23 11 13
Depreciation 8 21 21 28 28 29 57
Exceptional Income / Expenses 0 0 0 0 0 0 0
Profit Before Tax 5 -2 28 63 88 157 172
Provision for Tax 1 -0 9 19 22 42 41
Profit After Tax 4 -2 20 44 66 114 131
Adjustments -0 1 -1 0 0 0 -0
Profit After Adjustments 4 -1 18 44 66 114 131
Adjusted Earnings Per Share 0.6 -0.2 2.8 6.7 10 13.3 13.5

Yatharth Hospital Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 56 54 72 117 183 874 1605
Minority's Interest 3 8 8 0 0 0 32
Borrowings 146 157 164 207 201 75 1
Other Non-Current Liabilities 10 8 9 -1 -5 -8 -10
Total Current Liabilities 42 60 55 97 100 67 85
Total Liabilities 257 287 309 421 478 1009 1713
Fixed Assets 164 189 251 303 299 442 605
Other Non-Current Assets 69 69 9 8 3 57 252
Total Current Assets 24 29 49 109 176 510 856
Total Assets 257 287 309 421 478 1009 1713

Yatharth Hospital Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 13 0 2 5 12 37 113
Cash Flow from Operating Activities 17 39 44 60 64 -3 150
Cash Flow from Investing Activities -78 -43 -21 -52 -20 -226 -420
Cash Flow from Financing Activities 47 5 -19 -1 -18 304 519
Net Cash Inflow / Outflow -13 1 3 7 26 75 249
Closing Cash & Cash Equivalent 0 2 5 12 37 113 362

Yatharth Hospital Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.61 -0.2 2.77 6.74 10.04 13.33 13.55
CEPS(Rs) 1.89 2.94 6.13 10.99 14.24 16.75 19.48
DPS(Rs) 0 0 0 0 0 0 0
Book NAV/Share(Rs) 8.49 8.29 11.06 17.84 27.93 101.84 166.62
Core EBITDA Margin(%) 19.68 26.32 29.76 27.93 25.98 27.14 25.58
EBIT Margin(%) 11.68 11.84 21 21.39 21.23 25.1 20.92
Pre Tax Margin(%) 4.93 -1.7 12.3 15.74 16.85 23.39 19.51
PAT Margin (%) 3.91 -1.41 8.57 11.01 12.64 17.07 14.83
Cash Profit Margin (%) 12.14 13.17 17.56 17.97 17.93 21.44 21.32
ROA(%) 1.55 -0.76 6.57 12.11 14.64 15.4 9.59
ROE(%) 7.15 -3.74 30.91 46.65 43.87 21.65 10.53
ROCE(%) 5.4 7.53 19.3 27.07 26.88 23.97 14.35
Receivable days 42.75 36.03 42.83 55.67 67.76 91.08 109.54
Inventory Days 8.1 6.4 4.99 3.91 3.95 3.87 6.03
Payable days 489.53 331.95 165.15 134.8 153.39 138.44 120.68
PER(x) 0 0 0 0 0 31.3 31.35
Price/Book(x) 0 0 0 0 0 4.1 2.55
Dividend Yield(%) 0 0 0 0 0 0 0
EV/Net Sales(x) 1.77 1.36 0.86 0.78 0.56 5.11 4.15
EV/Core EBITDA(x) 8.9 5.16 2.88 2.74 2.11 17.34 15.14
Net Sales Growth(%) 0 43.41 56.59 75.33 29.77 28.88 31.31
EBIT Growth(%) 0 45.33 177.74 78.6 28.81 52.37 9.46
PAT Growth(%) 0 -151.62 1054.12 125.45 48.92 74.06 14.04
EPS Growth(%) 0 -132.72 1495.67 143.18 48.93 32.83 1.61
Debt/Equity(x) 2.96 3.4 2.57 2.21 1.44 0.1 0
Current Ratio(x) 0.57 0.48 0.9 1.13 1.77 7.59 10.12
Quick Ratio(x) 0.51 0.43 0.84 1.07 1.71 7.47 9.87
Interest Cover(x) 1.73 0.87 2.41 3.79 4.85 14.66 14.74
Total Debt/Mcap(x) 0 0 0 0 0 0.02 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 31% 30% 43% 0%
Operating Profit CAGR 22% 28% 44% 0%
PAT CAGR 15% 44% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 55% NA% NA% NA%
ROE Average 11% 25% 31% 22%
ROCE Average 14% 22% 22% 18%

Company Contact Information

Yatharth Hospital & Trauma Care Services Ltd.

J A 108, D L F Tower A Jasola District Centre South Delhi

IPO Lead Manager(s)

Yatharth Hospital & Trauma Care Services Ltd.

IIFL Securities Ltd.

Intensive Fiscal Services Pvt Ltd

Ambit Private Limited

Registrar Info

Yatharth Hospital & Trauma Care Services Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp